¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"LOSARTAN POTASSIUM"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
K+ Potassium; Electrolyte
KI(?) Potassium Iodide; ¿ÁÈ­Ä®·ý
KOH Potassium Hydroxide [HP 272-3]
DEPS distal effective potassium secretion
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LOS losartan
KATP ATP dependent potassium
K(ATP) ATP sensitive potassium
KATP channel ATP sensitive potassium channel
LPD Low Potassium Dextran
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® potassium ÇÑ±Û Ä®·ý
¼³¸í   
  ¿ø¼Ò ±âÈ£ 19¹øÀ̰í K·Î Ç¥½ÃÇϴ ȭÇÐÀû ¿ø¼Ò·Î ¼¼Æ÷ ³»¾×ÀÇ °¡Àå ¸¹Àº ¾çÀÌ¿ÂÀ̱⵵ ÇÏ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • potassium
    Ä®·ý
  • potassium chloride
    ¿°È­Ä®·ý
  • potassium sparing diuretic
    Ä®·ýº¸ÀüÀÌ´¢Á¦
  • potassium-losing nephritis
    Ä®·ý»ó½ÇÄáÆÏ¿°, Ä®·ý»ó½Ç½ÅÀå¿°
  • sodium-potassium pump
    ³ªÆ®·ýÄ®·ýÆßÇÁ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • potassium chloride
    ¿°È­Ä®·ý
  • potassium
    Ä®·ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • potassium chloride
    ¿°È­Ä®·ý
  • potassium sparing diuretic
    Ä®·ýº¸ÀüÀÌ´¢Á¦
  • potassium-losing nephritis
    Ä®·ý»ó½ÇÄáÆÏ¿°
  • potassium
    Ä®·ý
  • sodium-potassium pump
    ³ªÆ®·ýÄ®·ýÆßÇÁ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • potassium
    Ä®·ý
  • potassium
    Æ÷Ÿ½·
  • potassium ; kalium
    Æ÷Ÿ½·, Ä®·ý.
  • potassium channel
    Ä®·ýÅë·Î
  • potassium chloride
    ¿°È­Ä®·ý
  • potassium cyanide broth base
    û»êÄ®·ý¾×ü±âÃʹèÁö
  • potassium determination
    Ä®·ýÃøÁ¤
  • potassium dichromate
    ÁßÅ©·Ò»êÄ®·ý
  • potassium dihydrogen phosphate
    ÀλêÀ̼ö¼Ò(ì£â©áÈ)Ä®·ý
  • potassium losing nephritis
    Ä®·ý»ó½Ç¼º ½Å¿°.
  • potassium losing nephritis
    Ä®·ý»ó½Ç¼º ½Å¿°(¡­ßÃã÷àõ ãìæú)
  • potassium oxalate
    ¼ö»êÄ®·ý
  • potassium secretion
    Ä®·ýºÐºñ
  • potassium sparing diuretic
    Æ÷Ÿ½·<Ä®·ý>-º¸Á¸(¼º) ÀÌ´¢Á¦.
  • potassium urate crystal
    ¿ä»êÄ®·ý°áÁ¤
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cadmium potassium cyanide
    ½Ã¾ÈÈ­Ä«µå¹Ì¿òÄ®·ý.
  • cadmium potassium iodide
    ¿ä¿ÀµåÈ­Ä«µå¹ÅÄ®·ý.
  • caustic potassium
    °¡¼º(Ê´àõ)Ä®·ý.
  • exsiccated potassium alum
    °ÇÁ¶Ä®·ý¸í¹Ý.
  • potassium
    Ä®·ý
  • potassium
    Æ÷Ÿ½·
  • potassium ; kalium
    Æ÷Ÿ½·, Ä®·ý.
  • potassium channel
    Ä®·ýÅë·Î
  • potassium chloride
    ¿°È­Ä®·ý
  • potassium cyanide broth base
    û»êÄ®·ý¾×ü±âÃʹèÁö
  • potassium determination
    Ä®·ýÃøÁ¤
  • potassium dichromate
    ÁßÅ©·Ò»êÄ®·ý
  • potassium dihydrogen phosphate
    ÀλêÀ̼ö¼Ò(ì£â©áÈ)Ä®·ý
  • potassium losing nephritis
    Ä®·ý»ó½Ç¼º ½Å¿°.
  • potassium losing nephritis
    Ä®·ý»ó½Ç¼º ½Å¿°(¡­ßÃã÷àõ ãìæú)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • potassium
    Ä®·ý(K)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • potassium;kalium
    Æ÷Ÿ½·,Ä®·ý
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hetacillin potassium
    Ç쟽Ǹ° Ä®·ý
    Ç쟽Ǹ°ÀÇ Ä®·ý¿°. Ç×±Õ ÀÛ¿ëÀ» °¡Áö°í À־ ¾ÏÇǽǸ°°ú ºñ½ÁÇÏ°Ô »ç¿ëÇÑ´Ù.
  • potassium chloride
    ¿°È­ Ä®·ý
    KCl. Åõ¸íÇÑ ¹é»ö °áÁ¤ ³»Áö ¹é»ö °ú¸³»ó ºÐ¸»·Î¼­ °æ±¸Àû ¶Ç´Â Á¤¸Æ³» ÁÖ»ç·Î Åõ¿©ÇÏ¿© ÀüÇØÁú º¸ÃæÁ¦·Î »ç¿ëµÈ´Ù.
  • potassium hydroxide
    ¼ö½ÅÈ­ Ä®·ý
  • potassium metabolism
    Æ÷Ÿ½Ã¿ò ´ë»ç
  • potassium-sparing agent

    potency

    ÀáÀç´É, ÀáÀç·Â, È¿·Â, ¿ª°¡
  • sodium-potassium exchange resin
    ¼Òµð¿ò-Æ÷Ÿ½· ±³È¯ ¼öÁö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
losartan <chemical> An angiotensin II receptor antagonist with antihypertensive activity due mainly to selective blockade of at(1) receptors and the consequent reduced pressor effect of angiotensin II.
Pharmacological action: anti-arrhythmia agents, antihypertensive agents.
(12 Dec 1998)
alpha-phenoxyethylpenicillin potassium A penicillin preparation that is stable in gastric acid and is rapidly but only partially absorbed from the gastrointestinal tract.
Synonym: alpha-phenoxyethylpenicillin potassium, penicillin B.
(05 Mar 2000)
alpha-phenoxypropylpenicillin potassium A semisynthetic acid-stable penicillin that may be more effective than penicillin G.
Synonym: alpha-phenoxypropylpenicillin potassium.
(05 Mar 2000)
aluminum potassium sulfate AlK(SO4)2;an astringent and styptic; also used in veterinary medicine for ulcerative stomatitis, leukorrhoea, and conjunctivitis.
Synonym: potassium alum.
(05 Mar 2000)
amoxicillin-potassium clavulanate combination <chemical> A fixed-ratio combination of amoxicillin trihydrate, an aminopenicillin, and potassium clavulanate, a beta-lactamase inhibitor, used to treat broad-spectrum antibacterial infections, especially of resistant strains.
Pharmacological action: antibiotics, combined, antibiotics, lactam, enzyme inhibitors.
(12 Dec 1998)
antimony potassium tartrate <chemical> Bis(mu-(2,3-dihydroxybutanedioato(4-)-o(1),o(2):o(3),o(4)))diantimonate(2-) dipotassium trihydrate, stereoisomer. A schistosomicide possibly useful against other parasites. It has irritant emetic properties and may cause lethal cardiac toxicity among other adverse effects.
Pharmacological action: schistosomicides.
Chemical name: Antimonate(2-), bis(mu-(2,3-dihydroxybutanedioato(4-)-O1,O2:O3,O4))di-, dipotassium, trihydrate, stereoisomer
(12 Dec 1998)
canrenoate potassium <chemical> A synthetic pregnadiene derivative with anti-aldosterone activity.
Pharmacological action: aldosterone antagonists.
Chemical name: Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, monopotassium salt, (17alpha)-
(12 Dec 1998)
penicillin G potassium Potassium benzylpenicillin;the potassium salt of penicillin G, containing 85 to 90% penicillin G.
(05 Mar 2000)
phenethicillin potassium A penicillin preparation that is stable in gastric acid and is rapidly but only partially absorbed from the gastrointestinal tract.
Synonym: alpha-phenoxyethylpenicillin potassium, penicillin B.
(05 Mar 2000)
monobasic potassium phosphate KH2PO4;used as a urinary acidifier and buffer.
(05 Mar 2000)
potassium <chemistry> An Alkali element, occurring abundantly but always combined, as in the chloride, sulphate, carbonate, or silicate, in the minerals sylvite, kainite, orthoclase, muscovite, etc. Atomic weight 39.0. Symbol K (Kalium).
It is reduced from the carbonate as a soft white metal, lighter than water, which oxidizes with the greatest readiness, and, to be preserved, must be kept under liquid hydrocarbons, as naphtha or kerosene. Its compounds are very important, being used in glass making, soap making, in fertilisers, and in many drugs and chemicals. Potassium permanganate, the salt KMnO4, crystallizing in dark red prisms having a greenish surface colour, and dissolving in water with a beautiful purple red colour; used as an oxidizer and disinfectant. The name chameleon mineral is applied to this salt and also to potassium manganate. Potassium bitartrate. See Cream of tartar.
Origin: NL. See Potassa, Potash.
Source: Websters Dictionary
(01 Mar 1998)
potassium-40 A naturally occurring (0.0117%) radioactive potassium isotope; beta emitter with half-life of 1.26 billion years; chief source of natural radioactivity of living tissue.
(05 Mar 2000)
potassium-42 An artificial potassium isotope; beta emitter with half-life of 12.36 hr, used as a tracer in studies of potassium distribution in body fluid compartments and in localization of brain tumours.
(05 Mar 2000)
potassium-43 An artificial potassium isotope; a beta emitter with a half-life of 22.3 hr, used as a tracer in myocardial perfusion studies.
(05 Mar 2000)
potassium acetate An electrolyte replenisher, as well as a urinary and systemic alkaliser, which can be administered orally or by intravenous infusion. Formerly, it was used as a diuretic and expectorant.
(12 Dec 1998)
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÄÚÀÚÁ¤ - »õâ
Çѱ¹¿¥¿¡½ºµð
A59500031 Losartan Potassium
Àü¹®ÀǾàǰ | ±Þ¿©
ÄÚÀÚÁ¤100mg - »õâ
Çѱ¹¿¥¿¡½ºµð
A59500121 Losartan Potassium
Àü¹®ÀǾàǰ | ±Þ¿©
·ÎÀÚ»ìźÁ¤50mg - »õâ
À¯ÇѾçÇà
A04506811 Losartan Potassium
Àü¹®ÀǾàǰ | ±Þ¿©
Á߿ܷÎÀßźÁ¤ - »õâ
Áß¿Ü
A02107771 Losartan Potassium
Àü¹®ÀǾàǰ | ±Þ¿©
ÄÚ»ìÁ¤ - »õâ
ÇѼ­Á¦¾à
A03602781 Losartan Potassium
Àü¹®ÀǾàǰ | ±Þ¿©
°ÇÀÏ·ÎÀÚźĮ·ýÁ¤ - »õâ
°ÇÀÏÁ¦¾à
A03805871 Losartan Potassium
Àü¹®ÀǾàǰ | ±Þ¿©
·ÎŸ¸Æ½ºÁ¤ - »õâ
±ÙÈ­Á¦¾à
A07208541 Losartan Potassium
Àü¹®ÀǾàǰ | ±Þ¿©
·ÎÀÚ¸£ÅºÁ¤ - »õâ
´ë¿øÁ¦¾à
A12804331 Losartan Potassium
Àü¹®ÀǾàǰ | ±Þ¿©
¿¤ÀÚźÁ¤ - »õâ
µ¿È­¾àǰ°ø¾÷
A05705741 Losartan Potassium
Àü¹®ÀǾàǰ | ±Þ¿©
ÀßźÁ¤ - »õâ
µå¸²ÆÄ¸¶
A35104441 Losartan Potassium
Àü¹®ÀǾàǰ | ±Þ¿©
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
losartan potassium an angiotensin II receptor antagonist, used as an antihypertensive; administered orally.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • potassium
    Ä®·ý
  • potassium
    Æ÷Ÿ½·;Ä®·ý(±âÈ£ K)
  • potassium bromide
    ºê·ÒÈ­Ä®·ý
  • potassium carbonate
    ź»êÄ®¸®
  • potassium chlorate
    ¿°¼Ò»êÄ®·ý
  • potassium chloride
    ¿°È­Ä®·ý
  • potassium cyanide
    û»êÄ®¸®
  • potassium hydroxide
    ¼ö»êÈ­ Ä®·ý 9
  • potassium nitrate
    Áú»êÄ®·ý
  • potassium sulfate
    Ȳ»êÄ®·ý
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á